A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey
European Journal of Surgical Oncology · 2024-10 · 50 (10) · 108585
DOI: 10.1016/j.ejso.2024.108585 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2024-10. Verfasst von Carmela Caballero und 19 weiteren Autor:innen. Beteiligte Einrichtung: Breast International Group, Brussels, Belgium. Electronic address: carmela.caballero@bigagainstbc.org. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Patient Care Team, Surgical Oncology. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Surgical de-escalation aims to reduce morbidity without compromising oncological outcomes. Trials to de-escalate breast cancer (BC) surgery among exceptional responders after neoadjuvant systemic therapy (NST) are ongoing. Combined patient and clinician insights on this strategy are unknown. METHODS: The European Society of Surgical Oncology Young Surgeons Alumni Club (EYSAC) performed an online survey to evaluate the perspective of multidisciplinary teams (MDTs) on omission of surgery ("no surgery") following complete response to NST for early BC. The aim was to identify MDT considerations and perceived barriers to omission of BC surgery. Patient insights were obtained through a focused group discussion (FGD) with four members of the patient advocacy group, Guiding Researchers and Advocates to Scientific Partnerships (GRASP). RESULTS: The MDT survey had 248 responses, with 229 included for analysis. Criteria for a "no surgery" approach included: patient's tumor and nodal status before (39.7 %) and after (45.9 %) NST and comorbidities (44.3 %). The majority chose standard surgery for hypothetical cases with a complete response to NST. Barriers for implementation were lack of definitive trials (55.9 %), "no surgery" not being discussed in MDTs (28.8 %) and lack of essential diagnostic or therapeutic options (24 %). Patients expressed communication gaps about BC surgery, lack of trust regarding accuracy of imaging, fear of regret and psychosocial burden of choosing less extensive surgery. CONCLUSIONS: Before accepting "no surgery" after complete response to NST, MDTs and patients need level 1 evidence from clinical trials, access to standard diagnostic modalities and treatments. Patient's fear of regretting less surgery need to be acknowledged and addressed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Breast International Group, Brussels, Belgium. Electronic address: carmela.caballero@bigagainstbc.org.
- Department of Urology, Icahn School of Medicine at Mount Sinai Hospitals, New York, USA.
- Medical University Pleven, Pleven, Bulgaria.
- Breast Surgery Service, Memorial Sloan Kettering Cancer Center, New York, USA.
- Breast Unit, Champalimaud Clinical Centre, Champalimaud Foundation, Lisbon, Portugal; Surgical Oncology and Gynecologic Oncology Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
- Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Germany.
Zitieren
APA
Caballero, C., Lundon, D. J., Vasileva-Slaveva, M., Montagna, G., Bonci, E. A., Brandl, A., Smith, H., Kok, J. H. H., Holmberg, C. J., Sayyed, R., Santrac, N., Suppan, I., Kaul, P., Vassos, N., Lorenzon, L., Murphy, M., Ceelen, W., de Azambuja, E., McIntosh, S. A., & Rubio, I. T. (2024). A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey. European Journal of Surgical Oncology, 50(10), 108585. https://doi.org/10.1016/j.ejso.2024.108585
Vancouver
Caballero C, Lundon DJ, Vasileva-Slaveva M, Montagna G, Bonci EA, Brandl A, et al. A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey. European Journal of Surgical Oncology. 2024;50(10):108585. doi:10.1016/j.ejso.2024.108585
BibTeX
@article{Caballero2024,
author = {Caballero, Carmela and Lundon, Dara J and Vasileva-Slaveva, Mariela and Montagna, Giacomo and Bonci, Eduard-Alexandru and Brandl, Andreas and Smith, Henry and Kok, Johnn Henry Herrera and Holmberg, Carl-Jacob and Sayyed, Raza and Santrac, Nada and Suppan, Ina and Kaul, Pallvi and Vassos, Nikolaos and Lorenzon, Laura and Murphy, Marlena and Ceelen, Wim and de Azambuja, Evandro and McIntosh, Stuart A and Rubio, Isabel T},
title = {A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey},
journal = {European Journal of Surgical Oncology},
year = {2024},
volume = {50},
number = {10},
pages = {108585},
doi = {10.1016/j.ejso.2024.108585}
}
EUVIMED